19th Annual European Life Sciences CEO Forum
The event will be part of the Sachs Spring Life Sciences Week (#SSLSW), which will also incorporate the 1st Annual European Neuroscience Innovation Forum (#Sachs_ENIF). It will be held on the 3rd of March 2026, the day before ELSF, allowing relevant attendees to register for both events.
The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategies for 2026. The physical programme will consist of the usual panels and keynotes, which will be available on demand by the 12th of March. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.
The main programme for the 19th Annual ELSF is spread over 2 days (4th – 5th of March) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. The programme will consist of:
Day 1 (Wednesday, 4th of March):
- BioPharma Industry Panel: Outlook for 2026
- Venture & Private Equity Investor Roundtable
- Platforms & Novel Therapeutics Panel: Emerging Opportunities
- Autoimmune & Inflammatory Diseases Panel: New Approaches
- Obesity & Metabolic Disorders Panel: Innovation & Latest Trends
- Radiopharmaceuticals in Oncology Panel: Next-Gen Therapies & Opportunities
Day 2 (Thursday, 5th of March):
- BioPharma Dealmakers Roundtable: Challenges & Opportunities
- Greater China Biopharma Panel: Driving Cross-Border Dealmaking
- Partnering in Oncology Panel: Latest Developments in BD&L
- Oncology Innovation Panel: Latest Advances in Therapeutics
- Early-Stage Innovation & Investment Panel: Addressing the Funding Gap
- Rising Stars – Biotech Seed Companies Session